Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Qualification of HPLC System – V 2.0

Posted on By

Analytical Method Development: SOP for Qualification of HPLC System – V 2.0

Standard Operating Procedure for Qualification of HPLC System in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/344/2025
Supersedes SOP/AMD/344/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP outlines the procedure for the qualification of High-Performance Liquid Chromatography (HPLC) systems to ensure suitability for analytical applications. The qualification confirms that the system performs reliably and complies with

applicable pharmacopeial and regulatory requirements.

2. Scope

This SOP applies to all new and existing HPLC systems used in Analytical Method Development (AMD) for research, validation, and quality control activities in the pharmaceutical environment.

3. Responsibilities

  • Analytical Chemist: Performs the qualification tests and records results.
  • Engineering Department: Assists in utility and hardware-related verifications.
  • QA Officer: Reviews qualification reports and authorizes qualification status.
  • IT Administrator: Validates software configuration and data backup systems.
See also  Analytical Method Development: SOP for pH Determination of Semi-Solid Formulations - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring all HPLC systems are qualified prior to use and requalified as per requalification schedule or upon major maintenance.

5. Procedure

5.1 Qualification Phases

  1. Design Qualification (DQ): Verify that selected HPLC system specifications meet intended purpose.
  2. Installation Qualification (IQ): Confirm proper installation of hardware, software, and utilities.
  3. Operational Qualification (OQ): Evaluate operational controls, safety features, and software interface.
  4. Performance Qualification (PQ): Validate system performance using known standards.

5.2 Installation Qualification (IQ)

  1. Check utility connections (power, LAN, printer, etc.).
  2. Verify hardware serial numbers and configurations against purchase order.
  3. Install software with appropriate user rights and audit trail enabled.
  4. Fill Annexure-1 for IQ documentation.

5.3 Operational Qualification (OQ)

  1. Start the HPLC system and check baseline noise and drift.
  2. Test autosampler movement, injection precision, and pump gradient accuracy.
  3. Verify detector wavelength accuracy and linearity using caffeine solution.
  4. Log observations in Annexure-2.
See also  Analytical Method Development: Preparation of Calibration Curve in UV - V 2.0

5.4 Performance Qualification (PQ)

  1. Inject system suitability standard as per USP/EP guidelines.
  2. Calculate %RSD, tailing factor, and theoretical plates.
  3. Repeat over 3 days to confirm robustness and repeatability.
  4. Document results in Annexure-3.

5.5 Requalification Triggers

  • Major repairs or component replacements
  • Software upgrades or reinstallation
  • Long periods of inactivity (>6 months)
  • Audit observations or validation failures

5.6 Documentation and Approval

  1. Compile all annexures into a single qualification report.
  2. Submit for QA review and approval.
  3. Update the instrument qualification master list.

6. Abbreviations

  • HPLC: High-Performance Liquid Chromatography
  • DQ: Design Qualification
  • IQ: Installation Qualification
  • OQ: Operational Qualification
  • PQ: Performance Qualification

7. Documents

  1. Annexure-1: IQ Checklist
  2. Annexure-2: OQ Report
  3. Annexure-3: PQ Report
  4. Annexure-4: Qualification Summary

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP General Chapter <1058> – Analytical Instrument Qualification
  • 21 CFR Part 11 – Electronic Records and Signatures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Siddharth Patel Anjali Rao Dr. Renu Joshi
Designation Analyst QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Installation Qualification (IQ) Checklist

  • Model No., Serial No., Software Version
  • Power Supply Voltage Check
  • Network and Printer Configuration

Annexure-2: Operational Qualification (OQ) Report

Test Specification Observed Value Status
Baseline Noise < 0.01 AU 0.008 AU Pass
Pump Accuracy ±2% 1.5% Pass

Annexure-3: Performance Qualification (PQ) Report

System suitability parameters recorded for 6 replicate injections:

  • %RSD: 0.6%
  • Tailing Factor: 1.1
  • Theoretical Plates: 6500

Annexure-4: Qualification Summary

This document summarizes the qualification status and recommendations for use of the HPLC system post-approval.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 OQ and PQ steps revised as per audit findings Regulatory Compliance Dr. Renu Joshi
10/07/2022 1.0 Initial Issue New Instrument Qualification SOP QA Head
See also  Analytical Method Development: SOP for Bridging Study Between Two Analytical Methods - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0
Next Post: Elixir Department: SOP for Destructive vs. Non-Destructive Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version